Trial intelligence / Profile preview

Vonoprazan for prevention of recurrent ulcers in low-dose aspirin users

NCT01452763Phase 3Completed

Sponsor
Takeda
Start
Oct 2011
Primary completion
Apr 2013
Countries
1
01

Overview

A Phase 3 trial of vonoprazan in gastric ulcer, duodenal ulcer, sponsored by Takeda. Started Oct 2011; status: completed.

02

Drugs

vonoprazan
03

Conditions

gastric ulcerduodenal ulcer

Beyond the preview

Go deeper on NCT01452763.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01452763.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call